The latest announcement is out from Australian Clinical Labs Ltd ( (AU:ACL) ).
Australian Clinical Labs Ltd has experienced a change in the interests of its substantial holder, involving entities associated with KKR. The KKR Entities have increased their voting power in the company from 5.05% to 6.06%, indicating a stronger influence in the company’s decision-making process. This change could impact the company’s operations and strategic direction, potentially affecting its market positioning and stakeholder interests.
More about Australian Clinical Labs Ltd
YTD Price Performance: -12.65%
Average Trading Volume: 952,325
Technical Sentiment Signal: Buy
Current Market Cap: A$589.7M
See more insights into ACL stock on TipRanks’ Stock Analysis page.